NCT00291395 PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers Status TERMINATED Phase PHASE1
NCT00286923 Does Topiramate Adjust the Excitability of the Brain in Migraine Sufferers? Status UNKNOWN Phase N/A
NCT00285402 Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine Status UNKNOWN Phase PHASE2
NCT00283738 MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair Implant Status UNKNOWN Phase PHASE2/PHASE3
NCT00272896 Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs Status COMPLETED Phase NA
NCT00259649 Prospective Survey of Menstrual Migraine & Prevention With Eletriptan Status COMPLETED Phase PHASE4
NCT00257010 A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches Status COMPLETED Phase PHASE3
NCT00256802 The Diameter of the Middle Cerebral Artery Measured With Magnetic Resonance Angiography Status COMPLETED Phase NA
NCT00253175 A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Status COMPLETED Phase PHASE3
NCT00250458 Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea Status COMPLETED Phase PHASE3
NCT00246337 A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004) Status COMPLETED Phase PHASE2
NCT00240630 Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks Status COMPLETED Phase PHASE3
NCT00237302 A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in Children Status COMPLETED Phase PHASE3
NCT00236561 A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine Status COMPLETED Phase PHASE3
NCT00236509 A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine Status COMPLETED Phase PHASE3
NCT00231595 A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine Status COMPLETED Phase PHASE3
NCT00228605 Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain Status COMPLETED Phase PHASE3